(1)
DUBLIN, Jan. 14, 2021 /PRNewswire/ Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension (XR-NTX) administered once every three weeks plus oral extended-release bupropion administered daily as a combination treatment for adults with moderate or severe methamphetamine use disorder (MUD) were published today by Dr. Madhukar H. Trivedi et al. in the
New England Journal of Medicine (NEJM).
1 This is the second published study evaluating this combination regimen for the treatment of MUD.
2
The number of adults living with MUD has risen in recent years. In 2019, approximately 1 million adults in the U.S. reported having a methamphetamine use disorder-an increase of more than 50 percent since 2016.